INS and type 1 diabetes mellitus: The current standard therapy approach for T1DM involves basal-bolus insulin treatment with multiple daily injections (MDI) using analog insulin preparations; however, some patients with hypoglycemia or poor glycemic control may require continuous subcutaneous insulin infusion (CSII) via an insulin pump (17, 18).